REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

Title
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Authors
Keywords
Farnesoid X receptor, Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, NASH, Obeticholic acid
Journal
Contemporary Clinical Trials
Volume 84, Issue -, Pages 105803
Publisher
Elsevier BV
Online
2019-06-29
DOI
10.1016/j.cct.2019.06.017

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now